![](/img/cover-not-exists.png)
A Hybrid Phase I-II/III Clinical Trial Design Allowing Dose Re-Optimization in Phase III
Chapple, Andrew G., Thall, Peter F.Language:
english
Journal:
Biometrics
DOI:
10.1111/biom.12994
Date:
October, 2018
File:
PDF, 735 KB
english, 2018